Open Closing in a 6 months
Next Generation Sequencing Testing (NGS)
Descriptions
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
Keywords
quality audit execution
compliance review services
defect trend analysis
performance benchmarking
test process evaluation
QA documentation audit
validation review sessions
regulatory compliance checks
system readiness assessment
quality maturity diagnostics
Tender Lot Details
2 Tender Lots
Workflows
Status :
Procedure :
Suitable for SME :
Nationwide :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
Tenderbase ID :
Low Value :
High Value :
Buyer Information
Name :
Procurement contact
Name :
Phone :
Email :
Possible Competitors
1 Possible Competitors
